Keratinocyte Skin Cancer Surgery in the Elderly, Aged 80 Years and Over, is Effective and Safe
- Conditions
- Postoperative Complication
- Registration Number
- NCT06665581
- Lead Sponsor
- Juerg Hafner
- Brief Summary
As a result of a longer life expectancy and a change in UV exposure, physicians will be facing a growing number of elderly patients with keratinocyte cancer (KC) in fair-skinned populations. The purpose of this study is to better characterize KC surgery in patients over 80 years and older with different comorbid conditions and to investigate the incidence of complications associated with KC surgery.
A retrospective monocentric study of patients aged 80 and older, having surgery for KC in University Hospital of Zurich between January 1, 2022, and December 31, 2022, was conducted. Demographics, comorbidities, current medication, treatment type, tumor characteristics, surgical defect size, repair type and complications within 6 months after surgery were analyzed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 345
- Patients aged 80 and older, having surgery for KC in University Hospital of Zurich between January 1, 2022, and December 31, 2022
- Presence of a documented rejection.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of complications associated with KC surgery in individuals aged 80 years and older From January 1, 2022, to December 31, 2022
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
University Hospital Zurich, Dermatology Clinic
🇨ðŸ‡Zurich, Switzerland
University Hospital Zurich
🇨ðŸ‡Zurich, Switzerland